Literature DB >> 1497267

Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period.

A G van der Mey1, J H Frijns, C J Cornelisse, E N Brons, H van Dulken, H L Terpstra, P H Schmidt.   

Abstract

To acquire more insight into the results of treatment versus the "natural" course of glomus tumors, we studied the clinical data of 108 patients, in 58 of whom the disease was hereditary. During a period of 32 years (1956 to 1988), 175 tumors were diagnosed: 52 glomus jugulotympanic tumors, 32 vagal body tumors, and 91 carotid body tumors. The results of radical surgical treatment were disappointing for tumors located at the skull base, ie, nonradical in 59% (n = 23) of the cases, but very good for the carotid body tumors, for which 96% (n = 68) radical excision was achieved. Moreover, surgery at the level of the skull base dramatically increased morbidity, since it frequently induced cranial nerve palsy. During the follow-up period (maximal observation time 32 years, mean 13.5 years) none of the patients died of residual or recurrent tumor or developed distant metastases, irrespective of the mode and outcome of treatment. When these results are combined with the results of pedigree analysis, a realistic approximation of the "natural" course of the disease for both hereditary and nonfamilial tumors can be made. The results raise the question of whether this natural behavior is really improved by intervention. We conclude that removal of carotid body tumors and solitary vagal body tumors should be considered in order to prevent future morbidity. However, for skull base and bilateral glomus tumors a more conservative monitored "wait and see" policy can be sensible and should be considered in any proposal for treatment of head and neck paragangliomas.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1497267     DOI: 10.1177/000348949210100802

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  26 in total

1.  Normal life expectancy for paraganglioma patients: a 50-year-old cohort revisited.

Authors:  Jeanette de Flines; Jeroen Jansen; Reinier Elders; Maaike Siemers; Annette Vriends; Frederik Hes; Jean-Pierre Bayley; Andel van der Mey; Eleonora Corssmit
Journal:  Skull Base       Date:  2011-11

2.  Modern trends in the management of head and neck paragangliomas.

Authors:  Carlos Suárez; Verónica Fernández-Alvarez; Hartmut P H Neumann; Carsten C Boedeker; Christian Offergeld; Alessandra Rinaldo; Primož Strojan; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12       Impact factor: 2.503

Review 3.  Skull base surgery for benign skull base tumors.

Authors:  Ketan R Bulsara; Ossama Al-Mefty
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

4.  An update on the surgical treatment of temporal bone paraganglioma.

Authors:  K S Moe; D Li; T E Linder; S Schmid; U Fisch
Journal:  Skull Base Surg       Date:  1999

5.  Evolving concepts in the management of jugular paraganglioma: a comparison of radiotherapy and surgery in 88 cases.

Authors:  Patrice Tran Ba Huy; Romain Kania; Michèle Duet; Bernadette Dessard-Diana; Jean-Jacques Mazeron; Rania Benhamed
Journal:  Skull Base       Date:  2009-01

6.  Unusual eustachian tube mass: glomus tympanicum.

Authors:  C Lum; A M Keller; E Kassel; R Blend; J Waldron; J Rutka
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

7.  Management of paragangliomas. Clinical and angiographic aspects.

Authors:  R Van den Berg; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

8.  Lower cranial nerves function after surgical treatment of Fisch Class C and D tympanojugular paragangliomas.

Authors:  Andrea Bacciu; Marimar Medina; Hassen Ait Mimoune; Flavia D'Orazio; Enrico Pasanisi; Giorgio Peretti; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-12       Impact factor: 2.503

9.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.

Authors:  Carlos Suárez; Juan P Rodrigo; William M Mendenhall; Marc Hamoir; Carl E Silver; Vincent Grégoire; Primož Strojan; Hartmut P H Neumann; Rupert Obholzer; Christian Offergeld; Johannes A Langendijk; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-19       Impact factor: 2.503

Review 10.  Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities.

Authors:  A P van Gils; A R van Erkel; T H Falke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.